Canopy Growth (CGC) Net Income towards Common Stockholders (QoQ) (2019 - 2024)
Canopy Growth (CGC) Net Income towards Common Stockholders (QoQ) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Canopy Growth | 443.38 Mn | 196.37 Mn | 16.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 59.06% |
| Jun 30, 2024 | -13.49% |
| Mar 31, 2024 | -82.48% |
| Dec 31, 2023 | 107.51% |
| Sep 30, 2023 | -465.60% |
| Jun 30, 2023 | 47.18% |
| Mar 31, 2023 | -59.51% |
| Dec 31, 2022 | 67.02% |
| Sep 30, 2022 | 94.89% |
| Jun 30, 2022 | -301.93% |
| Mar 31, 2022 | -345.49% |
| Dec 31, 2021 | -606.26% |
| Sep 30, 2021 | -104.09% |
| Jun 30, 2021 | 462.27% |
| Mar 31, 2021 | 86.23% |
| Dec 31, 2020 | -777.90% |
| Sep 30, 2020 | 21.71% |
| Jun 30, 2020 | 91.53% |
| Mar 31, 2020 | -1,215.54% |
| Dec 31, 2019 | -145.17% |